[iframe style=”border:none” src=”//html5-player.libsyn.com/embed/episode/id/14413511/height/100/width//thumbnail/no/render-playlist/no/theme/custom/tdest_id/1418702/custom-color/3b4cdf” height=”100″ width=”100%” scrolling=”no” allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen]
We review the inpatient management in HFrEF, role of GDMT initiation & HF exacerbating drugs. We end the episode with a discussion on HFpEF & device therapies with Professor Carolyn Lam, a Senior Consultant of the National Heart Centre, Singapore and Professor of Duke-NUS Cardiovascular Academic Clinical Program.
Listen, Like, Subscribe, and give us a rating!